Stay updated on Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial
Sign up to get notified when there's something new on the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page.
Latest updates to the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.2%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference3%
- Check53 days agoChange DetectedThe website has added new features for downloading study data in various formats, while several links related to genetics, multiple myeloma, and clinical trials have been removed.SummaryDifference5%
- Check60 days agoChange DetectedNew resources related to multiple myeloma, including links to MedlinePlus and clinical trial information, have been added, enhancing the availability of information on this condition.SummaryDifference0.7%
- Check68 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference4%
Stay in the know with updates to Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page.